Lushang Freda Pharmaceutical Co.,Ltd. (600223.SS) SHH

Currency In CNY

AD

Valuation

Market Cap7.48B
Enterprise Value4.74B
P/E Ratio35.31
PEG Ratio-1.24
Price/Sales Ratio1.44
Price/Book Ratio1.28
Enterprise/Revenue0.74
Enterprise/EBITDA10.89

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin0.04
Operating Margin0.05
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.04

Income Statement

Revenue3.63B
Revenue/Share3.77
Gross Profit1.85B
EBITDA414.07M
Net Income187.75M
Diluted EPS0.18

Balance Sheet

Total Cash2.76B
Total Cash/Share2.71
Total Debt88.92M
Total Debt/Equity0.02
Current Ratio5.72
Book Value Per Share4.93

Price History

52-Week Change-31.78
52-Week High8.37
52-Week Low4.89
Moving Average 50 Days5.58
Moving Average 200 Days6.1

Statistics

Average Volume8.24M
Shares Outstanding1.02B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.06
Trailing Annual Dividend Yield1.05
Payout Ratio0.38
Last Split Factor5:4
Last Split DateFebruary 20, 2006
AD